(Q53976167)

23 May 2018

title

The glycine antagonist (+)-HA-966 injected into the nucleus accumbens stimulates locomotion in mice. (Rapid communication). (English)

1 reference

23 May 2018

1 reference

M Nilsson

1

1 reference

23 May 2018

M L Carlsson

series ordinal

2

1 reference

23 May 2018

publication date

1 January 1997

1 reference

23 May 2018

Journal of Neural Transmission

published in

1 reference

23 May 2018

volume

104

1 reference

23 May 2018

issue

4-5

1 reference

23 May 2018

page(s)

419-425

1 reference

23 May 2018

Neurochemical and behavioural investigations of the NMDA receptor-associated glycine site in the rat striatum: functional implications for treatment of parkinsonian symptoms.

cites work

1 reference

12 December 2020

Competitive antagonists and partial agonists at the glycine modulatory site of the mouse N-methyl-D-aspartate receptor

1 reference

12 December 2020

Multiple sites for the regulation of the N-methyl-D-aspartate receptor

1 reference

12 December 2020

The atypical neuroleptic profile of the glycine/N-methyl-D-aspartate receptor antagonist, L-701,324, in rodents

1 reference

12 December 2020

Psychiatric and neurological reactions to cycloserine in the treatment of tuberculosis.

1 reference

12 December 2020

Glutamate and glycine co-activate while polyamines merely modulate the NMDA receptor complex

1 reference

12 December 2020

Effects of D-cycloserine and (+)-HA-966 on the locomotor stimulation induced by NMDA antagonists and clonidine in monoamine-depleted mice

1 reference

12 December 2020

Are the disparate pharmacological profiles of competitive and un-competitive NMDA antagonists due to different baseline activities of distinct glutamatergic pathways? (Hypothesis)

1 reference

12 December 2020

Glycine is a coagonist at the NMDA receptor/channel complex

1 reference

12 December 2020

Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease

1 reference

12 December 2020

Behavioral effects mediated by the modulatory glycine site of the NMDA receptor in the anterodorsal striatum and nucleus accumbens.

1 reference

12 December 2020

Dose-finding trial of D-cycloserine added to neuroleptics for negative symptoms in schizophrenia

1 reference

12 December 2020

[Neurotoxicity of cycloserine; demonstration of its clinical & electroencephalographic manifestations from 30 French publications.]

1 reference

12 December 2020

Blockade of the locomotor stimulant effects of cocaine and methamphetamine by glutamate antagonists.

1 reference

12 December 2020

Cyloserine as an antidepressant agent

1 reference

12 December 2020

[Neuropsychiatric disorders & EEG changes during cycloserine therapy of pulmonary tuberculosis]

1 reference

12 December 2020

Centrally-administered glycine antagonists increase locomotion in monoamine-depleted mice

1 reference

12 December 2020

The glycine/NMDA receptor antagonist, R-(+)-HA-966, blocks activation of the mesolimbic dopaminergic system induced by phencyclidine and dizocilpine (MK-801) in rodents

1 reference

12 December 2020

Double-blind, placebo-controlled, crossover trial of glycine adjuvant therapy for treatment-resistant schizophrenia

1 reference

12 December 2020

D-cycloserine: a ligand for the N-methyl-D-aspartate coupled glycine receptor has partial agonist characteristics

1 reference

12 December 2020

d-Cycloserine adjuvant therapy to conventional neuroleptic treatment in schizophrenia: an open-label study

1 reference

12 December 2020

Stereoselectivity for the (R)-enantiomer of HA-966 (1-hydroxy-3-aminopyrrolidone-2) at the glycine site of the N-methyl-D-aspartate receptor complex

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01277660

1 reference

23 May 2018

1 reference

23 May 2018